Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Procter & Gamble Health LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500126NSE Symbol: PGHLP/E(TTM):34.78
ISIN Demat:INE199A01012Div & Yield %:1.29EPS(TTM):136.54
Book Value(Rs):485.4698795Market Cap ( Cr.):7883.67Face Value(Rs):10
    Change Company 
( In Cr)
 Jun 2023Jun 2022Jun 2021Jun 2020Dec 2018Dec 2017
INCOME :      
Sales Turnover 1229.621114.411008.731355.86848.99711.47
Excise Duty0.000.000.000.000.0013.34
Net Sales1229.621114.411008.731355.86848.99698.13
Other Income 18.3913.1918.1068.89767.9373.94
Stock Adjustments -2.854.75-1.7313.033.47-13.99
Total Income1245.161132.351025.101437.781620.39758.08
EXPENDITURE :      
Raw Materials 358.99344.55310.39444.47272.83222.95
Power & Fuel Cost12.8814.7012.9719.0912.2311.68
Employee Cost 206.17167.56153.66182.93131.27109.88
Other Manufacturing Expenses 90.8698.4390.82136.5689.7553.65
Selling and Administration Expenses 196.86203.91173.99257.28192.98188.49
Miscellaneous Expenses 36.3322.3319.1513.155.2520.52
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure902.09851.48760.981053.48704.31607.17
Operating Profit343.07280.87264.12384.30916.08150.91
Interest 0.770.420.800.000.000.00
Gross Profit342.30280.45263.32384.30916.08150.91
Depreciation28.1027.0830.0429.4521.1219.12
Profit Before Tax314.20253.37233.28354.85894.96131.79
Tax89.7960.8163.6094.7850.2244.54
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-5.060.04-7.125.996.02-6.66
Reported Net Profit229.47192.52176.80254.08838.7293.91
Extraordinary Items 0.51-0.40-0.31-2.256.1111.59
Adjusted Net Profit228.96192.92177.11256.33832.6182.32
Adjst. below Net Profit -1.840.700.42-159.42-6.97-6.21
P & L Balance brought forward237.07327.70532.261167.97361.12291.68
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 93.79283.85381.78730.3724.9018.26
P & L Balance carried down370.91237.07327.70532.261167.97361.12
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %615.00525.001300.002300.004400.00150.00
Earnings Per Share-Unit Curr138.23115.98106.51102.04505.2556.57
Earnings Per Share(Adj)-Unit Curr138.23115.98106.51102.04505.2556.57
Book Value-Unit Curr452.34371.38423.92545.99927.78441.72